4Filing Date: Aug 20, 2026

Tempus AI

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0002113721-26-000014
Total Value$930.0K
Trades7
Insiders1

Transaction Details

Schoenherr Thomas Edward
CEO, Diagnostics·Direct
Sell · Dispose
Class A Common Stock
Shares-3.09K
Price$55.97
Total Value$173.2K
Shares Owned After94.70K
Transaction DateAug 19, 2026
10b5-1
Footnotes ▸

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.38 to $56.01 inclusive.

Schoenherr Thomas Edward
CEO, Diagnostics·Direct
Sell · Dispose
Class A Common Stock
Shares-2.99K
Price$59.97
Total Value$179.6K
Shares Owned After91.11K
Transaction DateAug 19, 2026
10b5-1
Footnotes ▸

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.05 to $60.04 inclusive.

Schoenherr Thomas Edward
CEO, Diagnostics·Direct
Sell · Dispose
Class A Common Stock
Shares-500
Price$57.94
Total Value$29.0K
Shares Owned After94.10K
Transaction DateAug 19, 2026
10b5-1
Footnotes ▸

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.51 to $58.26 inclusive.

Schoenherr Thomas Edward
CEO, Diagnostics·Direct
Sell · Dispose
Class A Common Stock
Shares-494
Price$61.23
Total Value$30.2K
Shares Owned After89.72K
Transaction DateAug 19, 2026
10b5-1
Footnotes ▸

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.16 to $61.25 inclusive.

Schoenherr Thomas Edward
CEO, Diagnostics·Direct
Sell · Dispose
Class A Common Stock
Shares-100
Price$56.47
Total Value$5.6K
Shares Owned After94.60K
Transaction DateAug 19, 2026
10b5-1
Footnotes ▸

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026.

Schoenherr Thomas Edward
CEO, Diagnostics·Direct
Sell · Dispose
Class A Common Stock
Shares-900
Price$60.45
Total Value$54.4K
Shares Owned After90.21K
Transaction DateAug 19, 2026
10b5-1
Footnotes ▸

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.08 to $60.77 inclusive.

Schoenherr Thomas Edward
CEO, Diagnostics·Direct
Sell · Dispose
Class A Common Stock
Shares-9.23K
Price$49.61
Total Value$458.0K
Shares Owned After97.80K
Transaction DateAug 18, 2026
10b5-1
Footnotes ▸

Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.35 to $49.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8).

Post-Transaction Holdings

Schoenherr Thomas Edward · CEO, Diagnostics
SecuritySharesChange
Class A Common Stock94.70K-17.31K (-15.46%)
auto_awesome

Deep Analysis

Tempus AI Diagnostics CEO Thomas Edward Schoenherr sold 17,314 shares over two sessions — 9,232 as mandatory tax withholding, 8,082 under a 10b5-1 plan — cutting his direct stake by 16%.

lock
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-18 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: Tempus AI, Inc. (TEM) CIK: 0001717115 --- Reporting Owner --- Name: Schoenherr Thomas Edward CIK: 0002113721 Role: Officer (CEO, Diagnostics) --- Non-Derivative Transactions --- [Transaction #1] Security: Class A Common Stock Date: 2026-08-18 | Code: S (Open market sale) Shares: -9,232 | Price: $49.61 Total Value: $457,999.52 Shares Owned After: 97,797 | Ownership: D (Direct) Footnotes: [F1] Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. [F2] The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.35 to $49.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8). [Transaction #2] Security: Class A Common Stock Date: 2026-08-19 | Code: S (Open market sale) Shares: -3,094 | Price: $55.97 Total Value: $173,171.18 Shares Owned After: 94,703 | Ownership: D (Direct) Footnotes: [F3] This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. [F4] The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.38 to $56.01 inclusive. [Transaction #3] Security: Class A Common Stock Date: 2026-08-19 | Code: S (Open market sale) Shares: -100 | Price: $56.47 Total Value: $5,647.00 Shares Owned After: 94,603 | Ownership: D (Direct) Footnotes: [F3] This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. [Transaction #4] Security: Class A Common Stock Date: 2026-08-19 | Code: S (Open market sale) Shares: -500 | Price: $57.94 Total Value: $28,970.00 Shares Owned After: 94,103 | Ownership: D (Direct) Footnotes: [F3] This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. [F5] The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.51 to $58.26 inclusive. [Transaction #5] Security: Class A Common Stock Date: 2026-08-19 | Code: S (Open market sale) Shares: -2,994 | Price: $59.97 Total Value: $179,550.18 Shares Owned After: 91,109 | Ownership: D (Direct) Footnotes: [F3] This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. [F6] The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.05 to $60.04 inclusive. [Transaction #6] Security: Class A Common Stock Date: 2026-08-19 | Code: S (Open market sale) Shares: -900 | Price: $60.45 Total Value: $54,405.00 Shares Owned After: 90,209 | Ownership: D (Direct) Footnotes: [F3] This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. [F7] The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.08 to $60.77 inclusive. [Transaction #7] Security: Class A Common Stock Date: 2026-08-19 | Code: S (Open market sale) Shares: -494 | Price: $61.23 Total Value: $30,247.62 Shares Owned After: 89,715 | Ownership: D (Direct) Footnotes: [F3] This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. [F8] The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.16 to $61.25 inclusive. --- Footnotes (Complete Index) --- F1: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.35 to $49.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8). F3: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.38 to $56.01 inclusive. F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.51 to $58.26 inclusive. F6: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.05 to $60.04 inclusive. F7: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.08 to $60.77 inclusive. F8: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.16 to $61.25 inclusive. --- Signature --- /s/ /s/ Andrew Polovin, Attorney-in-Fact (2026-08-20)

keid analysis is for reference only and does not constitute investment advice.